Viva Biotech Highlights AI and Flow Chemistry Integration for Scalable Drug Synthesis

Viva Biotech hosted a webinar titled "AI x Flow Chemistry: From Bench to Business" to explore how artificial intelligence and flow chemistry are shaping modern synthesis workflows, announced in a press release. The event featured academic and industry experts discussing how these technologies are bridging the gap between molecular design and scalable execution.

Professor Jie Wu from the National University of Singapore presented advances in automated multistep synthesis, emphasizing the use of high speed circulation flow systems that combine batch and continuous processing. He introduced Chemical Recipe Files as a method to encode optimized synthesis protocols in a reproducible, machine executable format, supporting automated and scalable workflows.

Dr. Kejia Ding from Viva Biotech described how flow chemistry is being deployed across medicinal chemistry, process development, and manufacturing. Case studies included photochemical and difluoromethyl syntheses, where flow processing improved safety and scalability. A subsidiary, Langhua Pharma, demonstrated a continuous flow Curtius rearrangement that produced one thousand kilograms of material within two months.

The discussion highlighted how combining AI with automated synthesis and flow chemistry enables faster experimental validation of digitally designed molecules. Viva Biotech’s integrated platform connects discovery, synthesis, and manufacturing capabilities to support partners from early research through production.